Silo Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Silo Pharma?

Silo Pharma is funded by 32 Ventures.

Q: When was the last funding round for Silo Pharma?

Silo Pharma closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Silo Pharma raised to date?

Silo Pharma has raised obfuscated.

Overview

Silo Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Silo Pharma

CB Rank

22036

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

Founded

obfuscation

Public

Post-IPO Equity

Englewood Cliffs, New Jersey, United States

11-50

silopharma.com

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Key People

Eric Weisblum: Founder and CEO

Details

Legal Name

Silo Pharma Inc.

Also Known As

Uppercut Brands

Operating Status

Active

Stock Symbol

NASDAQ:SILO

Company Type

For Profit

Founders

Eric Weisblum

About the Company

Silo Pharma Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. It was founded in 2010 and is headquartered in Englewood Cliffs, New Jersey.

Phone Number

201-408-5126

Predictions & Insights

Growth Insight

See this Growth Insight

Silo Pharma is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Products & Services

SP-26 Ketamine Implant for Fibromyalgia

A subcutaneous time-released ketamine-based injectable implant designed for fibromyalgia treatment, providing regulated dosage and self-administration.

SPC-15 Targeted Prophylactic Treatment for Stress-Induced Affective Disorders

A novel serotonin 4 receptor agonist delivered intranasally to treat stress-induced affective disorders by bypassing the blood-brain barrier for direct brain targeting.

Research & Development

Silo Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Silo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
32 Ventures	—	Venture Round - Silo Pharma	—
32 Ventures	—	Venture Round - Silo Pharma	—
32 Ventures	—	Venture Round - Silo Pharma	—
32 Ventures	—	Venture Round - Silo Pharma	—
32 Ventures	—	Venture Round - Silo Pharma	—